News summary

The VAPB–PTPIP51 Complex at Mitochondria-Associated Endoplasmic Reticulum Membranes: Mechanisms and Implications for Cardiovascular Disease

Source: Frontiers - Health • Published: 21 Nov 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

Review links VAPB–PTPIP51-mediated ER–mitochondria coupling to cardiac injury.

The VAPB–PTPIP51 Complex at Mitochondria-Associated Endoplasmic Reticulum Membranes: Mechanisms and Implications for Cardiovascular Disease
Key Takeaways
  • PTPIP51 alteration was shown to remodel SR–mitochondrial contacts.
  • Modulating VAPB–PTPIP51 was reported to affect ischemia–reperfusion injury.
  • Causality for VAPB binding remains unproven and has not been established.
Read the full article at Frontiers - Health ↗

Continue exploring

Recommended MoL Picks

MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.